Vis enkel innførsel

dc.contributor.authorVistad, Ingvild
dc.contributor.authorSkorstad, Mette
dc.contributor.authorDemmelmaier, Ingrid
dc.contributor.authorSmåstuen, Milada Cvancarova
dc.contributor.authorLindemann, Kristina Yvonne Kathe
dc.contributor.authorWisløff, Torbjørn
dc.contributor.authorVan De Poll-Franse, Lonneke V
dc.contributor.authorBerntsen, Sveinung
dc.date.accessioned2022-02-22T14:52:25Z
dc.date.available2022-02-22T14:52:25Z
dc.date.created2022-01-11T21:44:38Z
dc.date.issued2021-07-12
dc.identifier.citationBMJ Open. 2021, 11 (7), .en_US
dc.identifier.issn2044-6055
dc.identifier.urihttps://hdl.handle.net/11250/2980829
dc.description.abstractIntroduction: The number of gynaecological cancer survivors is increasing and there is a need for a more sustainable model of follow-up care. Today’s follow-up model is time-consuming and patients have reported unmet needs regarding information about their cancer and strategies for managing the consequences of treatment. The main aim of this study is to assess health-related empowerment—in terms of patient education, psychosocial support, and promotion of physical activity—in a new follow-up model by comparing it to standard follow-up in a quasi-randomised study involving intervention hospitals and control hospitals. Methods and analysis: At the intervention hospitals, patients will be stratified by risk of recurrence and late effects to either 1 or 3 years’ follow-up. Nurses will replace doctors in half of the follow-up visits and focus in particular on patient education, self-management and physical activity. They will provide patients with information and guide them in goal setting and action planning. These measures will be reinforced by a smartphone application for monitoring symptoms and promoting physical activity. At the control hospitals, patients will be included in the standard follow-up programme. All patients will be asked to complete questionnaires at baseline and after 3, 6, 12, 24 and 36 months. Blood samples will be collected for biobanking at 3, 12 and 36 months. The primary outcome is health-related empowerment. Secondary outcomes include health-related quality of life, adherence to physical activity recommendations, time to recurrence, healthcare costs and changes in biomarkers. Changes in these outcomes will be analysed using generalised linear mixed models for repeated measures. Type of hospital (intervention or control), time (measurement point), and possible confounders will be included as fixed factors.en_US
dc.description.sponsorshipThe study is funded by the Norwegian Cancer Society (198057), the UNI Foundation (6845) and the South-Eastern Norway Regional Health Authorities (2019073).en_US
dc.language.isoengen_US
dc.publisherBMJ Publishing Groupen_US
dc.relation.ispartofseriesBMJ Open;Volume 11, Issue 7
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.subjectGynaecological canceren_US
dc.subjectCancer treatmenten_US
dc.subjectFollow-up careen_US
dc.subjectHealth-related empowermenten_US
dc.subjectConsequencesen_US
dc.titleLifestyle and Empowerment Techniques in Survivorship of Gynaecologic Oncology (LETSGO study): A study protocol for a multicentre longitudinal interventional study using mobile health technology and biobankingen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© Author(s) (or their employer(s)) 2021en_US
dc.source.articlenumbere050930en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doihttp://dx.doi.org/10.1136/bmjopen-2021-050930
dc.identifier.cristin1978923
dc.source.journalBMJ Openen_US
dc.source.volume11en_US
dc.source.issue7en_US
dc.source.pagenumber1-10en_US
dc.relation.projectDen Norske Kreftforening: 198057en_US
dc.relation.projectStiftelsen UNI: 6845en_US
dc.relation.projectHelse Sørøst: 2019073en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal